On January 25, 2021, Vancouver-based Kardium Inc., announced that they had raised US $115 million in a new financing round led by Fidelity Management & Research Company LLC., together with other follow-on participation funds and accounts advised by T. Rowe Price Associates, Inc.
Kardium announced that the new financing will be used to accelerate commercial growth of their Globe® Mapping and Ablation System in order to offer innovative atrial fibrillation treatment for millions of patients worldwide. The investment allows the company to accelerate commercial sales in Europe, as well as to begin the FDA clinical study for the Globe System.
Fasken advised Kardium Inc. with a team led by Shahrooz Nabavi (Corporate/Commercial and Corporate Finance) and included Iain Mant (Securities), Mike Coburn (Tax), Geoff Pedlow, Katie Peardon and Rasmeet Mohar (Corporate/Commercial and Corporate Finance).
Juridiction
- Colombie-Britannique
